These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Clinical significance of erythrocyte sorbitol-blood glucose ratios in type II diabetes mellitus. Aida K; Tawata M; Shindo H; Onaya T Diabetes Care; 1990 May; 13(5):461-7. PubMed ID: 2351023 [TBL] [Abstract][Full Text] [Related]
27. Negative association between erythrocyte reduced glutathione concentration and diabetic complications. Thornalley PJ; McLellan AC; Lo TW; Benn J; Sönksen PH Clin Sci (Lond); 1996 Nov; 91(5):575-82. PubMed ID: 8942396 [TBL] [Abstract][Full Text] [Related]
28. Increased levels of methylglyoxal-metabolizing enzymes in mononuclear and polymorphonuclear cells from insulin-dependent diabetic patients with diabetic complications: aldose reductase, glyoxalase I, and glyoxalase II--a clinical research center study. Ratliff DM; Vander Jagt DJ; Eaton RP; Vander Jagt DL J Clin Endocrinol Metab; 1996 Feb; 81(2):488-92. PubMed ID: 8636255 [TBL] [Abstract][Full Text] [Related]
29. Activities of aldose reductase, ATPases, and nucleotide concentrations of erythrocytes in patients with type 2 (non-insulin-dependent) diabetes mellitus. Song HP; Han XY; He Y; Kang TB; Wu HW Chin Med J (Engl); 1991 Oct; 104(10):818-24. PubMed ID: 1661222 [TBL] [Abstract][Full Text] [Related]
30. [Polymorphism of the dinucleotide repeat inside the aldose reductase gene in normal states and in patients with insulin-dependent diabetes mellitus with vascular complications]. Chistiakov DA; Turakulov RI; Girashko NM; Demurov LM; Rachiba IuM; Kondrat'ev IaIu; Milen'kaia TM; Shestakova MV; Dedov II; Nosikov VV Mol Biol (Mosk); 1997; 31(5):778-83. PubMed ID: 9454059 [No Abstract] [Full Text] [Related]
31. Prevalence and correlations of early microvascular complications in young type I diabetic patients: role of puberty. Bognetti E; Calori G; Meschi F; Macellaro P; Bonfanti R; Chiumello G J Pediatr Endocrinol Metab; 1997; 10(6):587-92. PubMed ID: 9467128 [TBL] [Abstract][Full Text] [Related]
32. The relationship between red blood cell Na/K-ATPase activities and diabetic complications in patients with type 2 diabetes mellitus. Koc B; Erten V; Yilmaz MI; Sonmez A; Kocar IH Endocrine; 2003 Aug; 21(3):273-8. PubMed ID: 14515013 [TBL] [Abstract][Full Text] [Related]
37. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients. Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415 [TBL] [Abstract][Full Text] [Related]
38. Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort. Maser RE; Usher D; Becker DJ; Drash AL; Kuller LH; Orchard TJ Diabetes Care; 1993 May; 16(5):755-8. PubMed ID: 8495616 [TBL] [Abstract][Full Text] [Related]
39. Effect of tolrestat, an aldose reductase inhibitor, on neutrophil respiratory burst activity in diabetic patients. Ihm SH; Yoo HJ; Park SW; Park CJ Metabolism; 1997 Jun; 46(6):634-8. PubMed ID: 9186297 [TBL] [Abstract][Full Text] [Related]
40. [Two forms of aldose reductase in erythrocytes from patients with insulin-dependent diabetes mellitus]. Shono NI; Rabinovich SE; Platonova LV; Diuzheva TG Vopr Med Khim; 1994; 40(5):45-8. PubMed ID: 7839671 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]